DEPB rate adjustments: formulations receive a reduced DEPB relative to bulk drugs; multi-drug cases follow circular. The public notice amends Appendix 28A for Chemicals to provide that formulations lacking specific DEPB rates (injections, syrups, oral suspensions, tablets, capsules, IV infusions) receive a reduced DEPB relative to the DEPB for the relevant bulk drug, with a separate rule for multi-bulk-drug formulations to follow the referenced policy circular; it also lists a DEPB entry for metal-fitted/bonded/unbonded rubber parts including engine mounting and automotive parts.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
DEPB rate adjustments: formulations receive a reduced DEPB relative to bulk drugs; multi-drug cases follow circular.
The public notice amends Appendix 28A for Chemicals to provide that formulations lacking specific DEPB rates (injections, syrups, oral suspensions, tablets, capsules, IV infusions) receive a reduced DEPB relative to the DEPB for the relevant bulk drug, with a separate rule for multi-bulk-drug formulations to follow the referenced policy circular; it also lists a DEPB entry for metal-fitted/bonded/unbonded rubber parts including engine mounting and automotive parts.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.